Jun 26, 2020 / 02:30PM GMT
Operator
Good morning, and welcome to the 2020 Onconova Therapeutics, Inc. Reconvened Annual Meeting of Shareholders. I would now like to turn the meeting over to Dr. Steven Fruchtman, President and CEO of Onconova. Dr. Fruchtman, please go ahead.
Steven M. Fruchtman - Onconova Therapeutics, Inc. - CEO, President & Director
Thank you so much, and good morning, ladies and gentlemen. Will the meeting please come to order? As you are aware, we adjourned our annual meeting of Shareholders on May 27, 2020; and similar to the annual meeting in May, we have adopted a virtual format for our reconvened annual meeting to protect the health and well-being of our employees, directors, shareholders and other stakeholders in light of the COVID-19 pandemic. I want to welcome all of you to the reconvened annual meeting of Shareholders of Onconova Therapeutics, Inc. I am Dr. Steven Fruchtman, President and CEO of Onconova Therapeutics, and I will be presiding at this reconvened meeting.
Mark Guerin, Onconova's Principal Financial Officer, will act as secretary of the meeting
Onconova Therapeutics Inc Annual Shareholders Meeting Transcript
Feb 29, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers